Company Overview of Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. operates as a clinical-stage research and development company. It focuses on cancer supportive care and gastroenterology. The company was formerly known as Sapphire Therapeutics, Inc. and changed its name to Helsinn Therapeutics (U.S.), Inc. as a result of its acquisition by Helsinn Healthcare S.A. The company was founded in 2000 and is based in Bridgewater, New Jersey. As of January 28, 2009, Helsinn Therapeutics (U.S.), Inc. operates as a subsidiary of Helsinn Healthcare S.A.
1140 US Highway 22
Bridgewater, NJ 08807
Founded in 2000
Key Executives for Helsinn Therapeutics (U.S.), Inc.
Helsinn Therapeutics (U.S.), Inc. Key Developments
Similar Private Companies By Industry
|Medco Research Institute, L.L.C.||United States|
|C5-6 Technologies Inc.||United States|
|ImmunoBiotics, Inc.||United States|
|Inviragen, Inc.||United States|
|Reflow Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Fredericksburg, VA | AstellasPosted: Mar 07
- Princeton, NJ | RGPPosted: Mar 05
- San Francisco, CA | PwCPosted: Apr 12
- Fresno, CA | AstellasPosted: Feb 20
Sponsored Financial Commentaries
To contact Helsinn Therapeutics (U.S.), Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.